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Endothelial microparticles (EMPs) are markers of endothelial
injury and activation. The role of EMPs in arterial hypertension is
not well understood and EMPs are increased both in arterial
hypertension and coronary artery disease (CAD). The data pre-
sented here show EMPs as deﬁned by CD31þ/41 , CD62eþ , and
CD144þ surface markers and vascular hemodynamic parameters
including ofﬁce and central blood pressure, heart rate, aortic
augmentation index, pulse wave velocity, ﬂow-mediated dilation,
nitroglycerin-mediated dilation, brachial artery diameter, hypere-
mic wall shear stress, and laser Doppler perfusion of the cutaneous
microcirculation of normotensives and hypertensives with and
without CAD.
& 2018 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).vier Inc. This is an open access article under the CC BY license
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ore speciﬁc subject area Vascular pathophysiology
ype of data Figures
ow data was acquired Flow-cytometry, sphygmomanometry, ultrasound, applanation tono-
metry, laser Doppler
ata format Raw, analyzed
xperimental factors Blood samples were taken along with vascular measurements in
humans
xperimental features Concentrations of endothelial microparticles in plasma and vascular
hemodynamic parameters in normotensives and patients with arterial
hypertension with and without stable coronary artery disease.ata source location Duesseldorf, Germany
ata accessibility Data are presented in this articleD
Value of the data The data will aid the evaluation of endothelial microparticles (EMPs) as integrated markers of
endothelial injury and activation.
 The data will help to understand the role of EMPs in the context of vascular changes in the
pathophysiology of vascular disease showing changes due to in arterial hypertension alone and the
interaction with coronary artery disease.
 The presented data will guide hypothesis-generation and design of further studies to understand
EMPs in the context of development of vascular pathologies.1. Data
The ﬁgures show endothelial microparticles (EMPs), as deﬁned by CD31þ/41 , CD62eþ , and
CD144þ surface markers (Fig. 1), and vascular hemodynamic parameters including ofﬁce and central
blood pressure, heart rate, aortic augmentation index, pulse wave velocity, ﬂow-mediated dilation,
nitroglycerin-mediated dilation, brachial artery diameter, hyperemic wall shear stress, and laser
Doppler perfusion of the cutaneous microcirculation (Fig.2) of normotensive and hypertensive
patients with and without CAD.2. Experimental design, materials and methods
2.1. Design, inclusion and exclusion criteria
We investigated circulating EMPs along with functional and mechanical characteristics of the
arterial system in 41 consecutive male subjects, 20 subjects without arterial hypertension and 21
subjects with arterial hypertension as deﬁned by blood pressure 4 140/90mmHg or ongoing anti-
hypertensive medication. The patients were recruited from the outpatient clinic. As the presence of
CAD might also affect circulating EMP values, we aimed at including 50% patients with stable CAD. In
all subjects, EMP subpopulations (CD31þ/41 , CD62eþ , CD144þ) were analyzed by ﬂow-cytometry
according to the expression of surface antigens. Hemodynamics and endothelial function of the
brachial artery were assessed as ﬂow-mediated dilatation (FMD). Pulse wave analyses including
central blood pressure, pulse wave velocity (PWV), and aortic augmentation index (AIX) were per-
formed by tonometry. Exclusion criteria were manifest peripheral artery, or cerebrovascular disease,
Fig. 1. Endothelial microparticle (EMP) plasma concentration in normotensive patients (columns with white background) and
patients with arterial hypertension (HT, columns with black background) with and without coronary artery disease (CAD,
columns with diagonal lines). EMP subpopulations were discriminated by ﬂow-cytometric analysis of platelet-free plasma
according to the expression of membrane-speciﬁc antigens ([A] CD31þ/CD41 , [B] CD62eþ , and [C] CD144þ; Values are mean
and standard deviations of log10 transformed values; * p o 0.05 vs normotensive non-CAD, # po 0.05 vs normotensive CAD.).
R. Sansone et al. / Data in Brief 19 (2018) 495–500 497acute inﬂammation (CRP4 0.6mg/dl), kidney failure (eGFR o 30ml/min), malignancies, and
arrhythmias (heart rhythm other than sinus).2.2. Characterization of EMP subpopulations by ﬂow cytometry
Citrated blood (6ml) was drawn from the cubital vein and processed within 2 h. Platelet-rich
plasma was obtained by centrifugation of whole blood at 300 g over 15min at room temperature.
Platelet-free plasma was obtained by 2 successive centrifugations of platelet-rich plasma at 10,000 g
for 5min at room temperature. Brieﬂy, samples were incubated for 30min with ﬂuorochrome-labeled
antibodies or matching isotype controls and analyzed in a Canto II ﬂow cytometer (Beckton Dick-
inson, Heidelberg, Germany). Microbead standards (1.0 mμ) were used to deﬁne MPs as o 1 μm in
diameter. The EMP subpopulations were deﬁned as CD31þ/CD41 , CD62eþ , or CD144þ events. The
total number of EMPs was quantiﬁed using ﬂow-count calibrator beads (20 l).2.3. Hemodynamic monitoring
The Task Force Monitor (CN-Systems, Graz, Austria) was used for continuous beat-to-beat
assessment of cardiovascular variables, including stroke volume, BP, heart rate, and total peripheral
resistance by impedance cardiography, which included ECG, phonocardiography, Finapres (Finapres-
Medical-Systems, Amsterdam, Netherlands), and BP monitoring system (Dynamap, Tampa, USA) at
the upper arm. We determined 24 h ambulatory BP measurements on the day before study days.
Central BP was derived from peripheral pulse wave analysis (SphygmoCor
s
, AtCor-Medical, Australia).2.4. Pulse wave analysis
Central blood pressure parameters including augmentation index (AIX) and pulse wave velocity
(PWV) were measured by radial applanation tonometry using the SphygmoCor
s
system in accordance
with the recommendations of the expert consensus on arterial stiffness [1]. Via a proprietary gen-
eralized transfer function, the pressure waveform of the ascending aorta was synthesized. PWV was
determined from tonometry measurements taken at the carotid and femoral artery.
Fig. 2. Hemodynamic characteristics of normotensive patients (columns with white background) and patients with arterial
hypertension (HT, columns with black background) with and without coronary artery disease (CAD, columns with diagonal
lines). (A) Ofﬁce and (B) central blood pressure (BP), (C) heart rate (HR), (D) aortic augmentation index (AIX), (E) pulse wave
velocity (PWV), (F) ﬂow-mediated dilation (FMD), (G) nitroglycerin-mediated dilation (NMD), (H) diastolic diameter of the
brachial artery (BA), (I) hyperemic wall shear stress (WSS), and (J) microvascular perfusion as measured by the hyperemic area
under the curve (AUC) with laser Doppler perfusion imaging (LDPI). (Values are mean and standard deviations; * p o 0.05 vs
normotensive non-CAD, # p o 0.05 vs normotensive CAD.).
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Brachial artery (BA) FMD was measured by ultrasound (10MHz transducer; Vivid I, GE) in com-
bination with an automated analysis system (Brachial Analyzer, Medical Imaging Applications, Iowa
City, IO) in a 21 °C temperature-controlled room after 15min of supine rest [2]. A forearm blood-
pressure cuff was placed distal to the cubital fossa and inﬂated to 250mmHg for 5min. Before cuff
inﬂation, the patients were instructed to keep the forearm muscles relaxed during ischemia to avoid
pain and all patients tolerated the cuff inﬂation well. Diameter and Doppler-ﬂow velocity were
measured at baseline and immediately after cuff deﬂation, at 20, 40, 60, and 80 s. FMD was expressed
relative to baseline diameters as: (diametermax  diameterbaseline)/diameterbaseline. Endothelium-
independent nitroglycerin-mediated dilation (NMD) was measured at 4min after 400mg nitrogly-
cerin (Nitrolingual forte, Pohl, Germany) in the brachial artery at the site of FMD measurements and
calculated identically.2.6. Wall shear stress (WSS)
WSS was assessed based on maximal brachial artery diameter and ﬂow velocity measurements
obtained during FMD measurements and was calculated as 8 * m * mean ﬂow velocity/mean diameter,
where blood viscosity (m) was assumed to be constant at 0.035 dyn/s cm2.2.7. Microvascular function assessed by non-invasive laser Doppler imaging
All investigations were performed using a scanning laser Doppler perfusion imager (PeriScan PIM
III System, Perimed, Sweden). The arm selected for measurements was immobilized to avoid moving
artifacts using a vacuum pillow containing polyurethane beads, which molds to the shape of the arm
(Germa, Sweden). The laser beam was positioned 15 cm above the forearm scanning a ﬁeld of 200
mm2 (region of interest [ROI] ¼ 8  8 pixels; three seconds per scan) on the volar site of the forearm.
Microvascular reactivity was assessed during post-occlusive reactive hyperemia PORH. Following the
baseline perfusion (one minute; 20 images), a blood pressure cuff located at the distal upper arm was
inﬂated to suprasystolic pressure over 5min. After the cuff release, the microvascular response on
reactive hyperemia was recorded. Data acquisition and analysis were performed by LDPI Win Soft-
ware (Perimed, Sweden) processing the perfusion as numerical values and color-coded-images [3].
The area under the curve (AUC) during reactive hyperemia was calculated with Prism 6 (GraphPad
software, La Jolla, USA).2.8. Statistical methods
Baseline characteristics of study subjects and results are described as average and standard
deviation. Subgroup analyses between the 4 groups of patients were performed with one way ANOVA
and Tukey post-hoc test. Normal distribution was conﬁrmed by Kolmogorov–Smirnov test for all
parameters except for subgroups of EMP data. As a conservative approach, we performed decadic
logarithmic transformation of all EMPs concentrations. P values of less than 0.05 were regarded as
statistically signiﬁcant. All Analyses were performed with SPSS 23 (IBM Corp.).Acknowledgements
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